Header Logo

Connection

UDDALAK BHARADWAJ to Immunotherapy, Active

Back to Details
This is a "connection" page, showing publications UDDALAK BHARADWAJ has written about Immunotherapy, Active.
UDDALAK BHARADWAJ
Connection Strength
0.074
Immunotherapy, Active
  1. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.